Connor Clark & Lunn Investment Management Ltd. Takes $661,000 Position in Crescent Capital BDC, Inc. (NASDAQ:CCAP)

Connor Clark & Lunn Investment Management Ltd. purchased a new position in shares of Crescent Capital BDC, Inc. (NASDAQ:CCAP - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 34,371 shares of the company's stock, valued at approximately $661,000. Connor Clark & Lunn Investment Management Ltd. owned approximately 0.09% of Crescent Capital BDC at the end of the most recent reporting period.

Several other hedge funds have also recently bought and sold shares of the company. Kovitz Investment Group Partners LLC acquired a new position in shares of Crescent Capital BDC during the 3rd quarter worth approximately $4,878,000. Franklin Resources Inc. raised its holdings in shares of Crescent Capital BDC by 35.2% in the third quarter. Franklin Resources Inc. now owns 256,279 shares of the company's stock worth $4,726,000 after acquiring an additional 66,713 shares during the last quarter. Raymond James Financial Inc. acquired a new position in shares of Crescent Capital BDC in the fourth quarter worth $3,750,000. Denali Advisors LLC lifted its position in shares of Crescent Capital BDC by 0.5% in the fourth quarter. Denali Advisors LLC now owns 183,783 shares of the company's stock valued at $3,532,000 after acquiring an additional 855 shares in the last quarter. Finally, HighTower Advisors LLC increased its position in Crescent Capital BDC by 0.5% during the 3rd quarter. HighTower Advisors LLC now owns 141,838 shares of the company's stock worth $2,624,000 after purchasing an additional 768 shares in the last quarter. 49.46% of the stock is owned by hedge funds and other institutional investors.

Remove Ads

Crescent Capital BDC Trading Up 0.2 %

NASDAQ CCAP traded up $0.04 during mid-day trading on Wednesday, hitting $17.82. The company's stock had a trading volume of 111,090 shares, compared to its average volume of 134,539. Crescent Capital BDC, Inc. has a 52-week low of $16.81 and a 52-week high of $20.19. The stock's fifty day simple moving average is $18.69 and its two-hundred day simple moving average is $18.80. The firm has a market capitalization of $660.44 million, a P/E ratio of 8.95 and a beta of 0.82. The company has a debt-to-equity ratio of 1.18, a current ratio of 1.32 and a quick ratio of 1.26.

Crescent Capital BDC (NASDAQ:CCAP - Get Free Report) last released its quarterly earnings results on Wednesday, February 19th. The company reported $0.55 EPS for the quarter, missing the consensus estimate of $0.56 by ($0.01). The company had revenue of $46.40 million for the quarter, compared to analyst estimates of $47.27 million. Crescent Capital BDC had a return on equity of 11.90% and a net margin of 37.32%. Research analysts expect that Crescent Capital BDC, Inc. will post 2.09 EPS for the current year.

Crescent Capital BDC Announces Dividend

The business also recently declared a dividend, which was paid on Friday, March 14th. Investors of record on Friday, February 28th were paid a $0.05 dividend. The ex-dividend date of this dividend was Friday, February 28th. Crescent Capital BDC's dividend payout ratio (DPR) is presently 84.42%.

Analyst Upgrades and Downgrades

Separately, Wells Fargo & Company reduced their target price on shares of Crescent Capital BDC from $19.00 to $18.00 and set an "equal weight" rating on the stock in a report on Friday, February 21st. One research analyst has rated the stock with a hold rating and four have issued a buy rating to the company's stock. According to data from MarketBeat, Crescent Capital BDC presently has a consensus rating of "Moderate Buy" and an average target price of $19.20.

About Crescent Capital BDC

Crescent Capital BDC, Inc is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.